166 related articles for article (PubMed ID: 24996009)
1. Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
Uzawa A; Mori M; Taniguchi J; Kuwabara S
Clin Exp Immunol; 2014 Nov; 178(2):245-52. PubMed ID: 24996009
[TBL] [Abstract][Full Text] [Related]
2. Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release.
Göbel K; Asaridou CM; Merker M; Eichler S; Herrmann AM; Geuß E; Ruck T; Schüngel L; Groeneweg L; Narayanan V; Schneider-Hohendorf T; Gross CC; Wiendl H; Kehrel BE; Kleinschnitz C; Meuth SG
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):271-276. PubMed ID: 30559188
[TBL] [Abstract][Full Text] [Related]
3. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
4. The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice.
Dutra RC; Leite DF; Bento AF; Manjavachi MN; Patrício ES; Figueiredo CP; Pesquero JB; Calixto JB
PLoS One; 2011; 6(11):e27875. PubMed ID: 22132157
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
6. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system.
Dutra RC; Moreira EL; Alberti TB; Marcon R; Prediger RD; Calixto JB
Brain Behav Immun; 2013 Oct; 33():90-101. PubMed ID: 23777652
[TBL] [Abstract][Full Text] [Related]
7. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
8. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels.
He Y; Du M; Gao Y; Liu H; Wang H; Wu X; Wang Z
PLoS One; 2013; 8(10):e76495. PubMed ID: 24124567
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.
Campbell DJ
Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):903-11. PubMed ID: 8846511
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
13. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.
Emanueli C; Grady EF; Madeddu P; Figini M; Bunnett NW; Parisi D; Regoli D; Geppetti P
Hypertension; 1998 Jun; 31(6):1299-304. PubMed ID: 9622145
[TBL] [Abstract][Full Text] [Related]
14. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
15. The kinin system: suggestions to broaden some prevailing concepts.
Erdös EG; Deddish PA
Int Immunopharmacol; 2002 Dec; 2(13-14):1741-6. PubMed ID: 12489787
[TBL] [Abstract][Full Text] [Related]
16. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
Waeber B; Juillerat-Jeanneret L; Aubert JF; Schapira M; Nussberger J; Brunner HR
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):175S-180S. PubMed ID: 2669913
[TBL] [Abstract][Full Text] [Related]
18. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
19. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease.
Stone RE; Liu S; Levy AM; Kashani N; Louie SG; Rodgers KE; Kelland EE; Lund BT
J Neuroimmune Pharmacol; 2020 Jun; 15(2):249-263. PubMed ID: 31828731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
